Tag: Clotild
Sensome initiates trial assessing tissue microsensor technology in peripheral artery disease
Sensome has announced enrolment of the first patients into a feasibility clinical study using the Clotild smart guidewire in peripheral artery disease (PAD). Clotild was...
LINNC 2023 examines neuroprotection, steerable microcatheters and other ‘next frontiers’
Neuroprotective agents and steerable microcatheter technologies were among a number of potential new interventional neuroradiology (INR) frontiers showcased and discussed at this year’s LINNC...
Sensome and Asahi Intecc partner to further development of Clotild smart...
Sensome and Asahi Intecc have today announced a collaboration to develop the next-generation Clotild smart guidewire, with Asahi Intecc taking on the manufacturing role...
AI-powered device delivers “amazing physiologic information” to guide thrombectomy treatments
The Clotild smart guidewire system (Sensome), which uses artificial intelligence (AI) to provide real-time insights on clot composition, is showing early promise in the...
